The 2nd Chinese Neuromodulation Conference will be held on 24 October 2008, in Shijiazhuang, China, immediately following will be the 2nd Asian Epilepsy Surgery Congress.
World Trade Plaza Hotel, Shijiazhuang, China
Organized by:
Chinese Neuromodulation Society (Organizing Committee)
Hebei General Hospital, Shijiazhuang, China
Sanbo Brain Institute, Beijing, China
Neuromodulation, a new medical discipline derived from integrated control of brain and bodily dysfunction based on sound scientific principles and technical innovations, has gained international eminence in its first past 10 years in the West. Similar interest is now aroused in China and some of its folk practice of “neruomodulation” can be said existent for centuries in the East.
The first international neuromodulation academy forum was successfully held from June 26th to 30th 2006 in Beijing. During the meeting, the chief Elliot Krames and other significant members of INS discussed with some Chinese experts to organize China Chapter of International Neuromodulation Society. After the meeting, a preliminary organizing group was set up. The Chapter submitted its official application to form a nonprofit organization to the Chinese government last year.
This Chinese Neuromodulation Conference (CNC) provides a fresh platform to discuss recent advances of neuromodulation in the academic science and clinical medicine, in conjunction with technical break-through by the international vendors, to meet in Shijiazhuang/China for the first time. The principal aim of this work is to educate and to incite interest in the investigation, training, and professional practice in the years to come.
China is an emerging economic power and growing concerns for the health welfares of its citizens is the issue of medical sciences and governmental policy making. In both physical and mental diseases, neuromodulatory techniques provide a new avenue for the treatment of neurological dysfunctions. These dysfunctions include psychiatric domains of psychosis, depression, anxiety, phobia, etc., and neurological domains of headache, various types of pain, cardiovascular regulation, motor disorders, epilepsy, or even possible in stroke recovery.
Some of the neuromodulatory treatments require neurosurgical interventions. In addition to other less invasive methods, it is necessary to obtain full understanding of the latest neuromodulatory technologies and training for the use of the best therapeutic and diagnostic equipments now available in the field. The level of care for patients after invasive implantation is an important aspect and determines success or failure. It is necessary to include all the organizational aspects that guarantee a high and continuous level of quality of care. Finally and inevitably, human brain mapping is essential in the study of brain function and dysfunction, so as to monitor treatment progress and mechanisms of the brain modulation as well as the direct effectiveness of the neuromodulation techniques.
We are looking forward to seeing you at CNS meeting in the golden October 2008.
Chinese Neuromodulation Conference Committee
